Mycoplasma Testing Market Size

Mycoplasma Testing Market size was valued at USD 1.09 billion in 2024 and is expected to cross USD 4.09 billion by the end of 2037, registering more than 12.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of mycoplasma testing is estimated at USD 1.2 billion.

The market is growing owing to rising demand for biosimilars and biologics. The production of biologics and biosimilars requires the use of various raw materials, including cell culture media, growth factors, and additives. These materials are the potential source of mycoplasma contamination. In correspondence, mycoplasma testing becomes crucial to ensure the safer use of these raw materials.

Moreover, the rising globalization of clinical trials brings new opportunities for the mycoplasma testing market growth. The world is fostering research initiatives through international collaboration. This leads to the exchange of cell lines, samples, and reagents among countries and increases the risk of mycoplasma contamination. Thus, the test is used to preserve the integrity of shared material.